ARCHIVES

Study: Angiopoietin-2 Levels May Predict Lenvatinib Response

This article is from The Cancer Letter archive.

Vol. 37 No. 10 | October 31, 2014

Download PDF Visit The Full Archive

Related Articles

Arbuck Leaves NCI to Guide BMS Oncology Pipeline.

September 7, 2001

MSKCC Wins Zoning Request For New Labs.

February 8, 2002

In Brief: Ford Named Acting Deputy Director, DCPC; Foundation Leads Oncology Administrators

June 3, 1994

Brothers Of Prostate Cancer Patients At Risk Of Diagnosis

August 27, 2010

Addition of Immune Stimulant To Yervoy Therapy Increases Overall Survival, Study Says

November 28, 2014

Obituary: Patricia Delaney, FDA Cancer Liaison.

June 6, 2008